drugset / Trial / NCT01496209

REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts

NCT01496209 ↗

Phase 1 Withdrawn Cedars-Sinai Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A double blinded and placebo-controlled, dose escalation, single-center safety and preliminary efficacy study of cardiospheres delivered via NOGA MYOSTAR injection catheter in subjects with chronic ischemic cardiomyopathy. The objective is to achieve and document myocardial regeneration in patients with chronic scar.

Timeline

Start
2015-07
Primary completion
2017-09
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogeneic Human CSps Cell therapy 1.5e+08 cells Other

Indications